Amundi Asset Management US’s TESARO, Inc. TSRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-5,500
Closed -$408 1727
2018
Q4
$408 Buy
+5,500
New +$264K ﹤0.01% 1297
2018
Q2
Sell
-7,790
Closed -$445K 1654
2018
Q1
$445K Buy
7,790
+113
+1% +$7.27K ﹤0.01% 1287
2017
Q4
$636K Sell
7,677
-97,305
-93% -$9.54M ﹤0.01% 1260
2017
Q3
$13.6M Sell
104,982
-212,771
-67% -$26.4M 0.04% 268
2017
Q2
$44.4M Buy
317,753
+210,273
+196% +$30.4M 0.15% 123
2017
Q1
$16.5M Sell
107,480
-33,542
-24% -$5.46M 0.06% 228
2016
Q4
$19M Sell
141,022
-31,199
-18% -$3.94M 0.07% 221
2016
Q3
$17.3M Buy
172,221
+54,218
+46% +$5.06M 0.06% 236
2016
Q2
$9.92M Buy
118,003
+62,715
+113% +$2.8M 0.04% 298
2016
Q1
$2.43M Sell
55,288
-69,061
-56% -$2.77M 0.01% 484
2015
Q4
$6.51M Buy
124,349
+5,118
+4% +$245K 0.02% 386
2015
Q3
$4.78M Buy
119,231
+3,688
+3% +$202K 0.02% 432
2015
Q2
$6.79M Sell
115,543
-13,687
-11% -$785K 0.02% 410
2015
Q1
$7.42M Buy
129,230
+559
+0.4% +$26.3K 0.03% 390
2014
Q4
$4.79M Buy
+128,671
New +$3.97M 0.02% 461

Other funds holding TSRO

Amundi Asset Management US's TSRO Position: Q1 2019 in Review

Amundi Asset Management US sold out of TESARO, Inc. (TSRO) in Q1 2019, closing a stake of 5,500 shares — an estimated $408 sold.

Amundi Asset Management US first reported a position in TSRO in Q4 2014 and held it in 15 quarters. The position peaked at $44.4M in Q2 2017. 2 funds tracked by Wall St. Rank hold TSRO as of Q1 2019.

  • Amundi Asset Management US reported no remaining TESARO, Inc. position as of Q1 2019 after selling out during the quarter.
  • Amundi Asset Management US sold 5,500 TESARO, Inc. shares in Q1 2019, an estimated $408.
  • Amundi Asset Management US first reported a position in TESARO, Inc. in Q4 2014 and held it in 15 quarters.
  • Amundi Asset Management US's TESARO, Inc. position peaked at $44.4M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held TESARO, Inc. as of Q1 2019.

Based on Amundi Asset Management US's 13F filing for Q1 2019, filed 13 May 2019.